The CLEAR Act amends federal law to establish new criminal penalties for obstructing Federal law enforcement officers operating in or on their vehicles. This legislation directly affects individuals who forcibly assault, resist, or interfere with officers from the Department of Homeland Security or Department of Justice while they are performing official duties in a law enforcement vehicle. The bill introduces enhanced penalties of up to 20 years in prison or a fine for such obstruction, expanding existing protections for officers engaged in vehicle operations. These provisions apply specifically to interactions involving Federal law enforcement vehicles and do not alter penalties for other types of obstruction.
This bill, titled the Future of Artificial Intelligence Innovation Act of 2026, creates a new Center for Artificial Intelligence Standards and Innovation within the National Institute of Standards and Technology to develop voluntary testing standards, evaluation tools, and best practices for AI systems. The bill establishes testbed programs that allow companies of all sizes to access federal computing resources and facilities for testing AI technologies, while also creating international coalitions with like-minded countries to align on AI standards and security measures. It authorizes federal agencies to award prizes for solving specific AI challenges and requires a report identifying regulatory barriers that may hinder AI innovation. The legislation also expands hiring authority for technical experts and adds requirements for auditing temporary workers involved in AI research.
The Family Vaccine Protection Act establishes formal procedures for the Advisory Committee on Immunization Practices (ACIP) within the Public Health Service Act. It requires the CDC Director to adopt ACIP vaccine recommendations unless they lack scientific support, in which case the Director must publish the rationale and notify Congress within 48 hours. The bill specifies the committee's composition, including required expertise for members and ex-officio members from key health agencies like the FDA and CMS. These provisions affect vaccine recommendations that determine coverage for health insurance plans and the Vaccines for Children Program, ensuring all recommendations are based on peer-reviewed scientific evidence.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
The Child Care Modernization Act of 2025 amends the Child Care and Development Block Grant Act to improve access to high-quality child care for working parents. It requires states to develop plans with input from parents, providers, and employers, and to set payment rates that cover providers' full costs including staff salaries and benefits. The bill creates a new grant program to expand child care supply through facilities improvements and support for providers serving priority populations like homeless children, rural communities, and children with disabilities. It clarifies eligibility requirements, including income limits for families and definitions for "eligible child" and "eligible activity." The act aims to increase the number of low-income children in high-quality child care settings while supporting the child care workforce.
This bill directs the U.S. Department of Health and Human Services to fund research on early detection and treatment of uterine fibroids (non-cancerous uterine tumors) and to award grants to states. The grants will support state programs that increase early detection through screening (like advanced imaging), patient navigation services, public education campaigns, and implementing research-backed strategies. It also requires additional research on disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. States receiving grants must report on program outcomes and research findings to Congress every two years. The bill directly affects healthcare systems, providers, and patients - particularly those facing disparities in gynecological care - by expanding access to early detection services.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
HR 6967, the Public Company Advisory Committee Act of 2026, establishes a new advisory committee within the Securities and Exchange Commission (SEC) to provide input on regulatory matters affecting public companies. The committee, composed of 10-20 members including public company executives, industry association leaders, and professional advisers (like lawyers and accountants), will advise the SEC on corporate governance, shareholder meetings, capital formation, and market rules - excluding enforcement actions. The SEC must publicly respond to each committee recommendation but is not required to adopt any suggestions. The committee operates without federal advisory committee regulations and cannot overlap with existing SEC advisory groups.
This bill requires the U.S. Secretary of State to work with the Secretary of Defense and submit a report to Congress within 180 days on emerging threats facing Estonia, Latvia, and Lithuania. The report will examine military, cyber, and political dangers from countries like Russia, Belarus, China, and Iran, while also assessing current U.S. and NATO security presence in the region. It includes recommendations for improving defense cooperation, cybersecurity, and democratic resilience in the Baltic states, and highlights opportunities to strengthen bilateral and multilateral partnerships. The legislation reflects Congress's view that supporting these NATO allies aligns with U.S. national security interests.
This bill, titled the Clean Water for All Life Act, would amend federal criminal law to prohibit chemical abortions unless a healthcare provider is physically present during the procedure. It directly affects individuals who prescribe, administer, or assist with chemical abortion drugs like mifepristone and misoprostol by making it a federal crime to provide these services without a physical exam and the provider's presence. The law requires that patients receive a catch kit and red bag medical waste container with disposal instructions, and it defines an unborn child as beginning at fertilization. Violations could result in up to five years in prison and a $50,000 fine for each occurrence. The bill does not address other forms of abortion or change existing state laws.
This bill reauthorizes and expands the Cooperative Watershed Management Program, which provides federal grants to local communities and Indian tribes for watershed restoration and management projects. It updates the program's definition to explicitly include Indian tribes as eligible recipients and increases the maximum annual grant amount from $100,000 to $150,000 for a minimum of three years. The legislation also adds provisions allowing grant continuations for up to two additional years based on satisfactory performance and enables multiple grant applications per year to increase funding opportunities. Finally, it authorizes $40 million in federal funding annually for fiscal years 2027 through 2031 to support the program.
